HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Arden stock registration

This article was originally published in The Rose Sheet

Executive Summary

Fragrance marketer files registration statement with Securities and Exchange Commission for up to $125 mil. in common stock that may be sold in one or more offerings. Arden currently has no immediate plans to sell its stock but "intends to evaluate market conditions over time." Proceeds would be used for general corporate purposes, including the repayment of debt," company says. Additional 1.4 mil. shares included in the statement are owned by Unilever subsidiary Conopco and represent the vested portion of company's 4.2 mil. shares of common stock issued in conjunction with the Elizabeth Arden acquisition from Unilever...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010458

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel